UNSPSC 85445504: The diagnosis of central nervous system stimulants

In this classification, this covers the group of activities that yields a diagnosis of other central nervous system stimulants. Other central nervous system stimulants is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y50.8.

UNSPSC 85445504 The diagnosis of central nervous system stimulants, a Commodity code, shows a mismatch between its nominal scope and recent state and local procurement activity. The code's description targets diagnostic procedures and clinical testing for central nervous system stimulants, yet the three most recent opportunities posted under this code involve diagnostic imaging systems (Picture Archiving and Communication System procurement), special education contracted services (speech therapists, occupational therapists, behavioral analysts), and temporary health professional staffing across ancillary clinical categories. None of these solicitations directly address stimulant diagnosis or substance-screening protocols. The recent activity suggests either inconsistent code tagging by the issuing bodies or a systematic misalignment between the code's intended use and how state and local procurement offices are applying it in practice.

San Mateo County in California, Birdville Independent School District in Texas, and Santa Clara County in California posted the three recent opportunities between July and October 2026. San Mateo Medical Center's RFP for Diagnostic Imaging PACS (due October 21, 2026) solicits enterprise-grade imaging system implementation with EPIC integration and data migration from an existing system; Birdville ISD's RFQ for special education contracted services (due October 21, 2026) covers 23 line items of therapists and evaluators on an as-needed basis across 30 campuses; Santa Clara Health System's RFSQ for temporary health professional staffing (due October 7, 2026) establishes a multiple-award qualified vendor pool across 13 ancillary clinical categories including audiology, radiology, and therapy services. The geographic concentration in California and Texas reflects recent posting activity, but the code itself shows limited relevant recent procurement momentum aligned with its stated scope of central nervous system stimulant diagnosis.